DHAUTONEX Quarterly Report Analysis Post-Rehabilitation Financial Improvement but High Dilution Risk from Convertible Bonds and Persistent Internal Control Weaknesses

Consolidated Q1 2026 revenue reached 14.36 billion KRW up 46.8% YoY from 9.78 billion but operating profit remained modest at 0.28 billion showing only slight improvement.
The 14.7 billion KRW 15th private convertible bond held by the largest shareholder NR First Fund has a conversion price of 500 KRW versus current market price of 4,200 KRW representing an 88% premium, converting into 29.4 million new shares or 71% dilution of existing shares.
Net debt to equity ratio surged from 8.51% at year-end 2025 to 21.04% at end of Q1 2026 while operating cash flow turned negative, increasing financial burden.
A material weakness in internal accounting control was reported indicating insufficient management review over closing processes and financial statement completeness.
The company is pursuing asset sales such as the disposal of DAYOU PLUS MEXICO stake and receivables to improve financial structure but litigation and contingent liabilities remain.
No dividends were paid and no share buyback or cancellation was executed offering no shareholder returns.
[AI Summary]DHAUTONEX shows revenue recovery post-rehabilitation but faces severe dilution risk from convertible bonds and rising net debt ratio. Internal control weaknesses undermine reliability and near-term shareholder value is likely to be impaired.